Topical application and microneedling enhance delivery research like the 2025 Kuceki study shows that combining GHK-Cu with microneedling (which creates micro-channels in the scalp) dramatically improves delivery to the target cells and produces measurable regrowth
Under physiological conditions, GHK occurs in equilibrium with plasma copper, forming a GHK-Cu complex, which is treated as the biologically active form of this peptide
This approach is often used when oral intake is insufficient or when elevated blood concentrations are desired for therapeutic support, including enhanced antioxidant capacity, support for detoxification pathways, and assistance in managing oxidative stress from environmental exposures or illness
Importantly, this anti-inflammatory action does not suppress immune function entirely like corticosteroids often do
"Clinical Practice Guideline for the Pharmacological Treatment of Chronic Insomnia in Adults." Journal of Clinical Sleep Medicine
Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992
